VYNE Therapeutics Statistics
Total Valuation
VYNE has a market cap or net worth of $7.79 million. The enterprise value is -$31.88 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VYNE has 25.47 million shares outstanding. The number of shares has increased by 42.50% in one year.
| Current Share Class | 25.47M |
| Shares Outstanding | 25.47M |
| Shares Change (YoY) | +42.50% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 3.42% |
| Owned by Institutions (%) | 30.80% |
| Float | 23.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 27.25 |
| Forward PS | 18.99 |
| PB Ratio | 0.15 |
| P/TBV Ratio | 0.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.60, with a Debt / Equity ratio of 0.00.
| Current Ratio | 7.60 |
| Quick Ratio | 6.79 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.73% and return on invested capital (ROIC) is -46.74%.
| Return on Equity (ROE) | -67.73% |
| Return on Assets (ROA) | -40.53% |
| Return on Invested Capital (ROIC) | -46.74% |
| Return on Capital Employed (ROCE) | -109.56% |
| Revenue Per Employee | $36,615 |
| Profits Per Employee | -$2.97M |
| Employee Count | 13 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VYNE has paid $4,000 in taxes.
| Income Tax | 4,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.82% in the last 52 weeks. The beta is 1.81, so VYNE's price volatility has been higher than the market average.
| Beta (5Y) | 1.81 |
| 52-Week Price Change | -83.82% |
| 50-Day Moving Average | 0.63 |
| 200-Day Moving Average | 1.65 |
| Relative Strength Index (RSI) | 32.10 |
| Average Volume (20 Days) | 1,716,443 |
Short Selling Information
The latest short interest is 1.34 million, so 5.25% of the outstanding shares have been sold short.
| Short Interest | 1.34M |
| Short Previous Month | 2.12M |
| Short % of Shares Out | 5.25% |
| Short % of Float | 5.75% |
| Short Ratio (days to cover) | 0.34 |
Income Statement
In the last 12 months, VYNE had revenue of $476,000 and -$38.55 million in losses. Loss per share was -$0.90.
| Revenue | 476,000 |
| Gross Profit | 476,000 |
| Operating Income | -42.60M |
| Pretax Income | -29.08M |
| Net Income | -38.55M |
| EBITDA | n/a |
| EBIT | -42.60M |
| Loss Per Share | -$0.90 |
Full Income StatementBalance Sheet
The company has $39.65 million in cash and $25,000 in debt, giving a net cash position of $39.62 million or $1.56 per share.
| Cash & Cash Equivalents | 39.65M |
| Total Debt | 25,000 |
| Net Cash | 39.62M |
| Net Cash Per Share | $1.56 |
| Equity (Book Value) | 38.88M |
| Book Value Per Share | 1.97 |
| Working Capital | 38.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$39.77 million and capital expenditures -$117,000, giving a free cash flow of -$39.89 million.
| Operating Cash Flow | -39.77M |
| Capital Expenditures | -117,000 |
| Free Cash Flow | -39.89M |
| FCF Per Share | -$1.57 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -8,949.37% |
| Pretax Margin | -8,091.81% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VYNE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -42.50% |
| Shareholder Yield | -42.50% |
| Earnings Yield | -497.61% |
| FCF Yield | -514.97% |
Analyst Forecast
The average price target for VYNE is $8.00, which is 2,514.38% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.00 |
| Price Target Difference | 2,514.38% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 152.08% |
| EPS Growth Forecast (5Y) | 23.65% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:18.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:18 |
Scores
VYNE has an Altman Z-Score of -22.26 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -22.26 |
| Piotroski F-Score | 1 |
